FIG. 2.
NVP resistance mutations detected in HIV-1 RNA and DNA from each woman by consensus sequencing (seq) and oligonucleotide ligation assay (OLA). Participants are listed by increasing time interval between sdNVP therapy and initiation of NVP-ART (ART start). Data for each specimen (RNA and DNA) at 10 days (10d) and 6 weeks following sdNVP therapy and just prior to ART start are shown for each woman, with the symbols in the key indicating the resistant codons detected. n/a, not available.